GB0411669D0 - Controlled-release dosage form - Google Patents
Controlled-release dosage formInfo
- Publication number
- GB0411669D0 GB0411669D0 GB0411669A GB0411669A GB0411669D0 GB 0411669 D0 GB0411669 D0 GB 0411669D0 GB 0411669 A GB0411669 A GB 0411669A GB 0411669 A GB0411669 A GB 0411669A GB 0411669 D0 GB0411669 D0 GB 0411669D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- controlled
- dosage form
- release dosage
- release
- dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0411669A GB0411669D0 (en) | 2004-05-25 | 2004-05-25 | Controlled-release dosage form |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0411669A GB0411669D0 (en) | 2004-05-25 | 2004-05-25 | Controlled-release dosage form |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0411669D0 true GB0411669D0 (en) | 2004-06-30 |
Family
ID=32671036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0411669A Ceased GB0411669D0 (en) | 2004-05-25 | 2004-05-25 | Controlled-release dosage form |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0411669D0 (en) |
-
2004
- 2004-05-25 GB GB0411669A patent/GB0411669D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL251539A0 (en) | Unitary pharmaceutical dosage form | |
IL182614A0 (en) | Pharmaceutical compounds | |
IL180706A0 (en) | Pharmaceutical dosage forms including rasagiline | |
GB0508306D0 (en) | Nicotine dosage forms | |
GB0513984D0 (en) | Dosage form | |
IL181229A0 (en) | Noncardiotoxic pharmaceutical compounds | |
GB0427455D0 (en) | Dosage forms | |
GB0423964D0 (en) | Dosage form | |
ZA200803152B (en) | Oramucosal pharmaceutical dosage form | |
GB0424323D0 (en) | Tablet | |
GB0512453D0 (en) | Dosage unit | |
ZA200605666B (en) | Solid dosage form | |
EP1937222A4 (en) | New sustained-release multiple unit dosage form | |
EP1716865A4 (en) | Paraoxonase-containing pharmaceutical preparation | |
GB0424742D0 (en) | Pharmaceutical compounds | |
GB0428554D0 (en) | Pharmaceutical compounds | |
GB0411667D0 (en) | Controlled-release dosage form | |
GB0411669D0 (en) | Controlled-release dosage form | |
GB0424994D0 (en) | Dosage form | |
GB0411047D0 (en) | Dosage form | |
GB0315019D0 (en) | Dosage form | |
GB0417777D0 (en) | Pharmaceutical combination | |
GB0522989D0 (en) | Dosage form | |
GB0412894D0 (en) | Pharmaceutical compounds | |
GB0428537D0 (en) | Pharmaceutical compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |